6.74
Relay Therapeutics Inc 주식(RLAY)의 최신 뉴스
Taking on analysts' expectations and winning: Relay Therapeutics Inc (RLAY) – Sete News - SETE News
SETE News
Relay Therapeutics: A 'Concept' Stock (NASDAQ:RLAY) - Seeking Alpha
Seeking Alpha
Market Update: Relay Therapeutics Inc (RLAY) Sees Positive Movement, Closing at 6.94 – DWinneX - The Dwinnex
The Dwinnex
A closer look at Relay Therapeutics Inc (RLAY)'s stock price trends – US Post News - US Post News
US Post News
(RLAY) On The My Stocks Page - Stock Traders Daily
Stock Traders Daily
Relay Therapeutics, Inc. (RLAY) Reports Q3 Loss, Lags Revenue Estimates - Yahoo New Zealand News
Yahoo New Zealand News
Relay Therapeutics Discloses Anticipated Registrational Path for RLY-4008 in Cholangiocarcinoma and Growing ... - Barchart
Barchart
Relay Therapeutics (NASDAQ:RLAY) Trading Down 4.7% - Defense World
Defense World
Relay Therapeutics Inc [RLAY] Shares Fall Approximately -43.48% Over the Year – Knox Daily - Knox Daily
Knox Daily
Sorrento Therapeutics (NASDAQ:SRNE) vs. Relay Therapeutics (NASDAQ:RLAY) Financial Review - Defense World
Defense World
Relay Therapeutics (NASDAQ:RLAY) Stock Price Down 4.7% - MarketBeat
MarketBeat
Healthy Upside Potential: Relay Therapeutics Inc (RLAY) – Sete News - SETE News
SETE News
Insider Sale Alert: Relay Therapeutics Inc [RLAY] – Is it Time to sell? – Knox Daily - Knox Daily
Knox Daily
Relay Therapeutics (NASDAQ:RLAY) Trading 5.8% Higher - MarketBeat
MarketBeat
Examining Relay Therapeutics Inc (RLAY) stock is warranted – US Post News - US Post News
US Post News
Stock Surge: Relay Therapeutics Inc (RLAY) Closes at 7.31, Marking a -6.58 Increase/Decrease – DWinneX - The Dwinnex
The Dwinnex
Relay Therapeutics, Inc. (RLAY) Reports Q3 Loss, Lags Revenue Estimates - Yahoo New Zealand News
Yahoo New Zealand News
Relay Therapeutics, Inc. (NASDAQ:RLAY) Short Interest Update - MarketBeat
MarketBeat
Relay Therapeutics Announces Initial RLY-4008 (lirafugratinib) Data Demonstrating Durable Responses Across ... - br.ADVFN.com
br.ADVFN.com
How to interpret Relay Therapeutics Inc (RLAY)'s stock chart patterns – US Post News - US Post News
US Post News
RLAY Stock Sees Surge of Approximately 7.63% in Last Five Days – Knox Daily - Knox Daily
Knox Daily
(RLAY) Trading Report - Stock Traders Daily
Stock Traders Daily
Relay Therapeutics Inc (RLAY): A New Perspective – Stocks Register - Stocks Register
Stocks Register
Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights - br.ADVFN.com
br.ADVFN.com
BVF Inc. IL Raises Stock Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Defense World
Relay Therapeutics, Inc. (NASDAQ:RLAY) Shares Acquired by BVF Inc. IL - MarketBeat
MarketBeat
Investor's Delight: Relay Therapeutics Inc (RLAY) Closes Weak at 7.23, Down -3.98 – DWinneX - The Dwinnex
The Dwinnex
Relay Therapeutics, Inc. (NASDAQ:RLAY) Shares Purchased by Caxton Associates LP - MarketBeat
MarketBeat
Insider Sale Alert: Relay Therapeutics Inc [RLAY] – Is it Time to sell? – Knox Daily - Knox Daily
Knox Daily
Bellevue Group AG Boosts Stock Position in Relay Therapeutics, Inc. (NASDAQ:RLAY) - MarketBeat
MarketBeat
Relay Therapeutics (NASDAQ:RLAY) Shares Down 5.7% - MarketBeat
MarketBeat
RLAY Stock Update: Relay Therapeutics Inc’s Banking’s Market Struggles and Potential Opportunities - The InvestChronicle
The InvestChronicle
Analysts Set Expectations for Relay Therapeutics, Inc.'s FY2025 Earnings (NASDAQ:RLAY) - MarketBeat
MarketBeat
Analysts Set Expectations for Relay Therapeutics, Inc.'s FY2025 Earnings (NASDAQ:RLAY) - MarketBeat
MarketBeat
HC Wainwright Weighs in on Relay Therapeutics, Inc.'s FY2025 Earnings (NASDAQ:RLAY) - Defense World
Defense World
Relay Therapeutics Chief Corporate Development Officer Peter Rahmer Sells 29% Of Holding - Simply Wall St
Simply Wall St
Relay Therapeutics Chief Corporate Development Officer Peter Rahmer Sells 29% Of Holding - Simply Wall St
Simply Wall St
Relay Therapeutics (NASDAQ:RLAY) Given Buy Rating at HC Wainwright - Defense World
Defense World
Relay Therapeutics shares receive positive outlook, Buy rating reiterated - Investing.com India
Investing.com India
Relay Therapeutics shares receive positive outlook, Buy rating reiterated - Investing.com South Africa
Investing.com South Africa
Relay Therapeutics shares receive positive outlook, Buy rating reiterated By Investing.com - Investing.com
Investing.com
Did Relay Therapeutics Inc (RLAY) perform well in the last session? – US Post News - US Post News
US Post News
HC Wainwright Reiterates "Buy" Rating for Relay Therapeutics (NASDAQ:RLAY) - MarketBeat
MarketBeat
Expert Ratings For Relay Therapeutics - Relay Therapeutics (NASDAQ:RLAY) - Benzinga
Benzinga
Stock Surge: Relay Therapeutics Inc (RLAY) Closes at 7.27, Marking a -0.95 Increase/Decrease – DWinneX - The Dwinnex
The Dwinnex
Peter Rahmer Sells 19864 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) Stock - Defense World
Defense World
HC Wainwright Reiterates "Buy" Rating for Relay Therapeutics (NASDAQ:RLAY) - MarketBeat
MarketBeat
Relay Therapeutics Inc (RLAY) Stock: Navigating a Year of Volatility - The InvestChronicle
The InvestChronicle
The Psychology of ImmunityBio Inc Inc. (IBRX) Price Performance: Understanding Market Sentiment - The InvestChronicle
The InvestChronicle
Relay Therapeutics Advances Cancer Treatment and Expands Drug Pipeline - TipRanks.com - TipRanks
TipRanks
자본화:
|
볼륨(24시간):